Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ABBV vs GSK✓SelectedUSD · GSKABBV vs GSK performance historyLatest closeAs of+0.94%11/20
Stock and ETF performance explorer

ABBV vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+128.6%
GSK return
+53.4%
Excess return
+75.3%
Maximum drawdown
-20.7%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D+0.9%-0.1%+1.1%+1.0%
7D-3.0%-5.3%+2.3%-0.9%
30D+0.5%-3.7%+4.1%+1.9%
3M+10.0%-7.3%+17.2%+13.0%
6M+36.6%-4.2%+40.8%+38.7%
YTD+29.0%+0.9%+28.1%+27.5%
1Y+28.5%+7.3%+21.2%+24.1%
3Y+128.6%+52.7%+75.9%+92.0%
All+128.6%+53.4%+75.3%+92.0%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling